Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Apellis Pharmaceuticals Inc (DE:1JK)
FRANKFURT:1JK
RESEARCH TOOLSreports
Apellis Pharmaceuticals (1JK) Ownership - Who Owns Apellis Pharmaceuticals?
0 Followers
Apellis Pharmaceuticals (1JK) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
6.01% Other Institutional Investors
93.99% Public Companies and
Individual Investors
The ownership structure of Apellis Pharmaceuticals (DE:1JK) stock is a mix of institutional, retail and individual investors. Approximately 6.01% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 93.99% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 15, 2024 | A. Sinclair Dunlop Director | Bought | $19785 |
| Mar 20, 2024 | A. Sinclair Dunlop Director | Sold | $1067993 |
| Mar 19, 2024 | Mark Jeffrey Delong Chief Business & Strat Officer | Sold | $564050 |
| Mar 18, 2024 | James George Chopas Vp/chief Accounting Officer | Sold | $10389 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $359 | |
| Dec 31, 2023 | Bought | $210288 | |
| Dec 31, 2023 | Sold | $359160 | |
| Dec 31, 2023 | Bought | $11147368 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,105 | Institution | ― | 99,324 | |
| 9,537 | Institution | ― | 450,003 | |
| 1,168,177 | Institution | ― | 55,120,432 | |
| 2,377,778 | Institution | ― | 112,195,455 | |
| 3,260 | Institution | ― | 153,823 | |
| 826,338 | Institution | ― | 38,990,759 | |
| 5,578 | Institution | ― | 263,198 | |
| 1,130 | Institution | ― | 53,319 | |
| 1,047 | Institution | ― | 49,403 | |
| 9,103,457 | Institution | ― | 429,546,619 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 86,939 | Institution | ― | 4,102,217 | |
| 1,333,249 | Institution | ― | 62,909,354 | |
| 71,063 | Institution | ― | 3,353,108 | |
| 18,827 | Institution | ― | 888,352 | |
| 94,165 | Institution | ― | 4,443,176 | |
| 10,959 | Institution | ― | 517,100 | |
| 32,889 | Institution | ― | 1,551,867 | |
| 11,026 | Institution | ― | 520,262 | |
| 2,202 | Institution | ― | 103,901 | |
| 78,403 | Institution | ― | 3,699,446 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Apellis Pharmaceuticals Inc (DE:1JK)?
According to the latest TipRanks data, approximately 6.01% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 93.99% is held by retail investors.
What percentage of Apellis Pharmaceuticals Inc (DE:1JK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.01% of Apellis Pharmaceuticals Inc (DE:1JK) stock is held by institutional investors.
What percentage of Apellis Pharmaceuticals Inc (DE:1JK) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.99% of Apellis Pharmaceuticals Inc (DE:1JK) stock is held by retail investors.
Who owns the most shares of Apellis Pharmaceuticals Inc (DE:1JK)?
Avantis owns the most shares of Apellis Pharmaceuticals Inc (DE:1JK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.